Search For "next wave of clinical development"
Gilead Sciences to start trials of inhaled version of remdesivir
Updated : 6 years, 1 month ago IST
California [USA], June 23 (ANI): US-based biopharmaceutical major Gilead Sciences will soon start clinical trials for inhaled formulation of its anti-viral drug remdesivir used for the treatment of Covid-19.
Read More